Tim Reese

Dr. Tim Reese

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in HPB
Verified
Journal Article
Open access
PDF file
MJMaximilian Jara
Maximilian Jara
TRTim Reese
Tim Reese
MMMaciej Malinowski
Maciej Malinowski
EVErika Valle
Erika Valle
DSDaniel Seehofer
Daniel Seehofer
MSMartin Stockmann
Martin Stockmann
Post-hepatectomy liver failure has a major impact on patient outcome. This study aims to explore the impact of the integration of a novel patient-centred evaluation, the LiMAx algorithm, on perioperative patient outcome after hepatectomy. Trends in perioperative variables and morbidity and mortality rates in 1170 consecutive patients undergoing elective hepatectomy between January 2006 and December 2011 were analysed retrospectively. Propensity score matching was used to compare the effects on morbidity and mortality of the integration of the LiMAx algorithm into clinical practice. Over the study period, the proportion of complex hepatectomies increased from 29.1% in 2006 to 37.7% in 2011 (P = 0.034). Similarly, the proportion of patients with liver cirrhosis selected for hepatic surgery rose from 6.9% in 2006 to 11.3% in 2011 (P = 0.039). Despite these increases, rates of post-hepatectomy liver failure fell from 24.7% in 2006 to 9.0% in 2011 (P < 0.001) and liver failure-related postoperative mortality decreased from 4.0% in 2006 to 0.9% in 2011 (P = 0.014). Propensity score matching was associated with reduced rates of post-hepatectomy liver failure [24.7% (n = 77) versus 11.2% (n = 35); P < 0.001] and related mortality [3.8% (n = 12) versus 1.0% (n = 3); P = 0.035]. Postoperative liver failure and postoperative liver failure-related mortality decreased in patients undergoing hepatectomy following the implementation of the LiMAx algorithm.

1 July 2021 in HPB
Verified
Journal Article
Closed access
TRTim Reese
Tim Reese
FKFabian Kröger
Fabian Kröger
GMGeorgios Makridis
Georgios Makridis
RDRichard Drexler
Richard Drexler
MJMaximilian Jusufi
Maximilian Jusufi
KOKarl J. Oldhafer
Karl J. Oldhafer

6 June 2018 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
COChristian E. Oberkofler
Christian E. Oberkofler
TRTim Reese
Tim Reese
DRDimitri A. Raptis
Dimitri A. Raptis
CKChristoph Kuemmerli
Christoph Kuemmerli
OROlivier de Rougemont
Olivier de Rougemont
HPHenrik Petrowsky
Henrik Petrowsky

11 July 2018 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
TRTim Reese
Tim Reese
DRDimitri A. Raptis
Dimitri A. Raptis
COChristian E. Oberkofler
Christian E. Oberkofler
OROlivier de Rougemont
Olivier de Rougemont
GGGeorg Györi
Georg Györi
HPHenrik Petrowsky
Henrik Petrowsky
Although aorto‐hepatic conduits (AHC) provide an effective technique for arterialization in liver transplantation (LT), when the native recipient artery is unusable, various publications report higher occlusion rates and impaired outcome compared to conventional anastomoses. This systematic review and meta‐analysis investigates the published evidence of outcome and risk of AHC in LT using bibliographic databases and following the PRISMA guidelines. Primary and secondary outcome were artery occlusion as well as graft and patient survival. Twenty‐three retrospective studies were identified with a total of 22,113 LT, of whom 1,900 patients (9%) received an AHC. An AHC was used in 33% of retransplantations. Early artery occlusion occurred in 7% (3‐16%) of patients with AHC, compared to 2% (1‐3%) without conduit (OR 3.70; 1.63‐8.38; p=0.001). The retransplantation rate after occlusion was not significantly different in both groups (OR 1.46; 0.67‐3.18; p=0.35). Graft (HR 1.38; 1.17‐1.63; p<0.001) and patient (HR 1.57; 1.12‐2.20; p=0.009) survival was significantly lower in the AHC compared to the non‐conduit group. In contrast, graft survival in retransplantations was comparable (HR 1.00; 0.82‐1.22; p=0.986). Although AHC provide an important rescue option, when regular revascularization is not feasible during LT, transplant surgeons should be alert of the potential risk of inferior outcome.

1 January 2021 in Pancreatology
Verified
Journal Article
Closed access
RDRichard Drexler
Richard Drexler
RFRebecca Fahy
Rebecca Fahy
MKMirco Küchler
Mirco Küchler
KWKim C. Wagner
Kim C. Wagner
TRTim Reese
Tim Reese
KOKarl J. Oldhafer
Karl J. Oldhafer

26 September 2019 in Der Chirurg
Verified
Journal Article
Closed access
PDF file
Karl J. OldhaferKarl J. Oldhafer
Karl J. Oldhafer
TRTim Reese
Tim Reese
MFMohammad Fard-Aghaie
Mohammad Fard-Aghaie
ASAlina Strohmaier
Alina Strohmaier
GMGeorgios Makridis
Georgios Makridis
KWKim C. Wagner
Kim C. Wagner